Applied dna and evvivax announce positive preliminary results of phase i clinical trial for lineardna™ covid-19 vaccine candidate in felines

Stony brook, n.y. & rome--(business wire)---- $apdn #cathealth--preliminary results of phase i clinical trial yields high titers of sars-cov-2 neutralizing antibodies from all cohort members.

APDN Ratings Summary

APDN Quant Ranking